Literature DB >> 15123530

Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women.

Linda R Peterson1, Pilar Herrero, Kenneth B Schechtman, Susan B Racette, Alan D Waggoner, Zulia Kisrieva-Ware, Carmen Dence, Samuel Klein, JoAnn Marsala, Timothy Meyer, Robert J Gropler.   

Abstract

BACKGROUND: Obesity is a risk factor for impaired cardiac performance, particularly in women. Animal studies suggest that alterations in myocardial fatty acid metabolism and efficiency in obesity can cause decreased cardiac performance. In the present study, we tested the hypothesis that myocardial fatty acid metabolism and efficiency are abnormal in obese women. METHODS AND
RESULTS: We studied 31 young women (body mass index [BMI] 19 to 52 kg/m2); 19 were obese (BMI >30 kg/m2). Myocardial oxygen consumption (MVO2) and fatty acid uptake (MFAUp), utilization (MFAU), and oxidation (MFAO) were quantified by positron emission tomography. Cardiac work was measured by echocardiography, and efficiency was calculated as work/MVO2. BMI correlated with MVO2 (r=0.58, P=0.0006), MFAUp (r=0.42, P<0.05), and efficiency (r=-0.40, P<0.05). Insulin resistance, quantified by the glucose area under the curve (AUC) during an oral glucose tolerance test, correlated with MFAUp (r=0.55, P<0.005), MFAU (r=0.62, P<0.001), and MFAO (r=0.58, P<0.005). A multivariate, stepwise regression analysis showed that BMI was the only independent predictor of MVO2 and efficiency (P=0.0005 and P<0.05, respectively). Glucose AUC was the only independent predictor of MFAUp, MFAU, and MFAO (P<0.05, <0.005, and <0.005, respectively).
CONCLUSIONS: In young women, obesity is a significant predictor of increased MVO2 and decreased efficiency, and insulin resistance is a robust predictor of MFAUp, MFAU, and MFAO. This increase in fatty acid metabolism and decrease in efficiency is concordant with observations made in experimental models of obesity. These metabolic changes may play a role in the pathogenesis of decreased cardiac performance in obese women.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15123530     DOI: 10.1161/01.CIR.0000127959.28627.F8

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  221 in total

1.  Potentiation of abnormalities in myocardial metabolism with the development of diabetes in women with obesity and insulin resistance.

Authors:  Janet B McGill; Linda R Peterson; Pilar Herrero; Ibrahim M Saeed; Carol Recklein; Andrew R Coggan; Amanda J Demoss; Kenneth B Schechtman; Carmen S Dence; Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2011-04-23       Impact factor: 5.952

2.  An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart.

Authors:  Xiangping Fang; Rengasamy Palanivel; Justin Cresser; Kristin Schram; Riya Ganguly; Farah S L Thong; Joseph Tuinei; Aimin Xu; E Dale Abel; Gary Sweeney
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-08-24       Impact factor: 4.310

Review 3.  Bariatric surgery to unload the stressed heart: a metabolic hypothesis.

Authors:  Mohamed F Algahim; Shiraj Sen; Heinrich Taegtmeyer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-02-03       Impact factor: 4.733

4.  Synthesis and evaluation of 15-(4-(2-[¹⁸F]Fluoroethoxy)phenyl)pentadecanoic acid: a potential PET tracer for studying myocardial fatty acid metabolism.

Authors:  Zhude Tu; Shihong Li; Terry L Sharp; Pilar Herrero; Carmen S Dence; Robert J Gropler; Robert H Mach
Journal:  Bioconjug Chem       Date:  2010-11-11       Impact factor: 4.774

5.  Estrogenic Impact on Cardiac Ischemic/Reperfusion Injury.

Authors:  Sivaporn Sivasinprasasn; Krekwit Shinlapawittayatorn; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  J Cardiovasc Transl Res       Date:  2016-01-19       Impact factor: 4.132

6.  Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart.

Authors:  Sihem Boudina; Heiko Bugger; Sandra Sena; Brian T O'Neill; Vlad G Zaha; Olesya Ilkun; Jordan J Wright; Pradip K Mazumder; Eric Palfreyman; Timothy J Tidwell; Heather Theobald; Oleh Khalimonchuk; Benjamin Wayment; Xiaoming Sheng; Kenneth J Rodnick; Ryan Centini; Dong Chen; Sheldon E Litwin; Bart E Weimer; E Dale Abel
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

Review 7.  Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.

Authors:  Olesya Ilkun; Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  Impact of sex on the heart's metabolic and functional responses to diabetic therapies.

Authors:  Matthew R Lyons; Linda R Peterson; Janet B McGill; Pilar Herrero; Andrew R Coggan; Ibrahim M Saeed; Carol Recklein; Kenneth B Schechtman; Robert J Gropler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-16       Impact factor: 4.733

9.  Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts.

Authors:  Imene Tabbi-Anneni; Jonathan Buchanan; Robert C Cooksey; E Dale Abel
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

Review 10.  Managing cardiovascular risk in overweight children and adolescents.

Authors:  Sarita Dhuper; Sujatha Buddhe; Sunil Patel
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.